Product Images Nifedipine

NIFEdipine is a medication that comes in a 60mg extended-release tablet form. This medication should be kept in its original container, protected from light and moisture, and stored at USP controlled room temperature. It is important to swallow the tablet whole and not to bite or divide it. The medication is Rx-only and the dosage should be followed as instructed in the package insert. The active ingredient Nifedipine is manufactured by Ingenus Pharmaceuticals, LLC and repackaged by Northwind Pharmaceuticals. The lot number is 0000000000, and the medication can be identified with GTIN 00351655386521 and S/N 000000000000000.*

Nifedipine extended-release tablets may cause adverse effects such as headache, fatigue, dizziness, constipation, and nausea. These effects were reported in 15.8%, 5.9%, 4.1%, 3.3%, and 33% of the 707 patients who took the medication. In comparison, the placebo group reported rates of 9.8%, 4.1%, 4.5%, and 23% for headache, fatigue, dizziness, and constipation, respectively.*

This is a table of adverse effects experienced by patients taking Nifedipine Capsules compared to the placebo group. The table lists the percentage of patients who experienced each adverse effect, including dizziness, lightheadedness, and giddiness, flushing and heat sensation, headache, weakness, nausea and heartburn, muscle cramps and tremor, peripheral edema, nervousness and mood changes, palpitations, dyspnea, cough, and wheezing, and nasal congestion and sore throat. The sample sizes for each group are also provided.*